✦ LIBER ✦

Sustained long-term remission of chronic plaque psoriasis upon treatment with multiple courses of alefacept

Book ID: 116583465
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 52 KB
Volume: 58
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2007.10.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multiple alefacept courses for long-term

Multiple alefacept courses for long-term remission of plaque psoriasis

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

The safety profile and sustained remissi

The safety profile and sustained remission associated with response to multiple courses of intramuscular alefacept for treatment of chronic plaque psoriasis

✍ Janet L. Roberts; Jean-Paul Ortonne; Jerry K.L. Tan; Eileen Jaracz; Ellen Franke 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Multiple courses of alefacept for the tr

Multiple courses of alefacept for the treatment of psoriatic nail disease in patients with chronic plaque psoriasis

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 54 KB

The efficacy of multiple courses of alef

The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis

✍ Alan Menter; Jennifer C. Cather; Diane Baker; Harold F. Farber; Mark Lebwohl; Mo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 102 KB

An extended 16-week course of alefacept

An extended 16-week course of alefacept in conjunction with reduced T-cell monitoring for the treatment of chronic plaque psoriasis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Long-term outcome of severe chronic plaq

Long-term outcome of severe chronic plaque psoriasis following treatment with high-dose topical calcipotriol

✍ Bleiker; Bourke; Mumford; Hutchinson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

We have previously reported the effectiveness of high-dose calcipotriol in extensive psoriasis. We now report the long-term outcome in patients following this treatment. Twenty-eight patients with severe psoriasis were treated as in-patients with high-dose topical calcipotriol for 2 weeks. There was